Extra J&J troubles: Vaccine manufacturing halted and extra attainable clot circumstances

https://ift.tt/eA8V8J
Enlarge / The Emergent BioSolutions plant, a producing associate for Johnson & Johnson’s Covid-19 vaccine, in Baltimore, Maryland, on April 9, 2021. Getty | Saul Loeb Covid-19 Protection Extra J&J troubles: Vaccine manufacturing halted and extra attainable clot circumstances SARS-CoV-2 variant present in Brazil: Extra infectious, might restrict immunity CDC knowledgeable panel punts on deciding …
Source: https://ift.tt/3goZVVt